In a groundbreaking study published in 2026, researchers have unveiled a novel and highly promising therapeutic approach to combat triple-negative...

In the rapidly evolving landscape of oncology, neuroendocrine tumors (NETs) present a unique and daunting challenge for clinicians and researchers...

In a groundbreaking discovery poised to reshape the understanding and treatment of chemotherapy-induced heart damage, a collaborative team of researchers...

In a groundbreaking discovery that challenges long-standing paradigms in cancer immunotherapy, researchers from Mass General Brigham, Dana-Farber Cancer Institute, and...

Emerging research from the collaborative efforts of scientists at Marshall University Joan C. Edwards School of Medicine and The Hebrew...

In a groundbreaking development for the treatment of immune thrombocytopenia (ITP), a recent phase 2 clinical trial has demonstrated that...

In a groundbreaking advance within the rapidly evolving field of immunotherapy, researchers have unveiled a novel strategy to optimize chimeric...

The Damon Runyon Cancer Research Foundation has announced the selection of 13 outstanding postdoctoral scientists as its 2026 Damon Runyon...

In a groundbreaking study published in the prestigious journal Immunity, researchers from Oregon Health & Science University (OHSU) have shed...

The American Association for Cancer Research (AACR) will host its prestigious Annual Meeting in San Diego, California, from April 17...